drugset / Trial / NCT01464879
A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a Phase 2 clinical trial in adult hypogonadal males with baseline morning serum testosterone concentrations \<300 ng/dL. The purpose of this study is to evaluate the pharmacokinetics of FE 999303, delivered using an applicator in comparison to hand application
Timeline
- Start
- 2011-12
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 1.25 ml | Topical |
| Subject | Testosterone | Small molecule | 2.5 ml | Topical |
| Subject | Testosterone | Small molecule | 3.75 ml | Topical |